Calliditas Therapeutics Ab ADR (CALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CALT | COLL | ELVN | ||
| Company | Calliditas Therapeutics Ab ADR | Collegium Pharma | Enliven Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 40.00 | 38.93 | 22.92 | ||
| High | 43.00 | 39.41 | 23.55 | ||
| Low | 40.00 | 38.29 | 22.39 | ||
| Last | 40.00 | 39.07 | 23.19 | ||
| Change | -0.16 | +0.14 | +0.12 | ||
| % Change | -0.40% | +0.36% | +0.52% | ||
| Volume | 9,700 | 1,646,100 | 747,300 | ||
| 20-Day Average Volume | 9,090 | 352,430 | 175,050 | ||
| Previous Close | 40.16 | 38.93 | 23.07 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 40.31 | 37.53 | 22.41 | ||
| 20-Day Raw Stochastic | 24.24% | 91.32% | 65.14% | ||
| 20-Day Relative Strength | 53.26% | 60.62% | 52.75% | ||
| Weighted Alpha | +42.89 | +67.33 | +15.79 | ||
| Today's Opinion | 88% Buy | 100% Buy | 56% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 09/13/24 | +4.19% since 09/13/24 | +3.90% since 09/13/24 | ||
| Low | 39.20 on 09/18/24 | 36.89 on 09/16/24 | 21.37 on 09/17/24 | ||
| High | 43.00 on 09/20/24 | 39.45 on 09/19/24 | 23.60 on 09/19/24 | ||
| 1-Month | |||||
| %Chg | -1.01% since 08/20/24 | +7.90% since 08/20/24 | +3.99% since 08/20/24 | ||
| Low | 39.04 on 09/13/24 | 35.07 on 09/10/24 | 21.34 on 08/30/24 | ||
| High | 43.00 on 09/20/24 | 39.45 on 09/19/24 | 24.18 on 09/10/24 | ||
| 3-Month | |||||
| %Chg | +3.39% since 06/20/24 | +23.72% since 06/20/24 | +10.22% since 06/20/24 | ||
| Low | 35.77 on 08/15/24 | 31.15 on 06/26/24 | 19.88 on 06/26/24 | ||
| High | 43.00 on 09/20/24 | 39.58 on 07/30/24 | 27.67 on 07/29/24 | ||
| 6-Month | |||||
| %Chg | +87.79% since 03/20/24 | +0.72% since 03/20/24 | +20.72% since 03/20/24 | ||
| Low | 16.00 on 04/16/24 | 30.42 on 05/10/24 | 15.96 on 04/19/24 | ||
| High | 43.00 on 09/20/24 | 40.95 on 03/28/24 | 27.67 on 07/29/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,196,366 | 1,273,595 | 1,085,143 | ||
| Shares Outstanding, K | 29,790 | 32,715 | 47,037 | ||
| Annual Sales | 113,810,000 | 566,770,000 | 0 | ||
| Annual Net Income | -43,960,000 | 48,160,000 | -71,580,000 | ||
| Last Quarter Sales | 52,280,000 | 145,280,000 | 0 | ||
| Last Quarter Net Income | -4,430,000 | 19,610,000 | -19,950,000 | ||
| 60-Month Beta | 1.77 | 0.94 | 1.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 08/13/24 | 1.62 on 08/08/24 | -0.41 on 08/13/24 | ||
| Latest Earnings Date | 11/11/24 | 11/05/24 | 08/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 7.17 | 0.00 | ||